BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21250935)

  • 21. Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.
    Bhambhvani HP; Rodrigues AJ; Umeh-Garcia MC; Hayden Gephart M
    Neurosurg Clin N Am; 2020 Oct; 31(4):613-625. PubMed ID: 32921356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis.
    Torrejón D; Oliveira M; Cortes J; Sanchez-Olle G; Gómez P; Bellet M; Saura C; Peg V; Rovira A; Di Cosimo S
    Breast; 2013 Feb; 22(1):19-23. PubMed ID: 23137566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal low-grade neoplasm with leptomeningeal dissemination mimicking tuberculous meningitis in a child.
    Demir HA; Varan A; Akyüz C; Söylemezoğlu F; Cila A; Büyükpamukçu M
    Childs Nerv Syst; 2011 Jan; 27(1):187-92. PubMed ID: 20635183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
    Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
    J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis.
    Liu J; Jia H; Yang Y; Dai W; Su X; Zhao G
    J Int Med Res; 2009; 37(6):1913-20. PubMed ID: 20146891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical analysis of leptomeningeal carcinomatosis in 4 cases].
    Bao J; Hu XQ; Jiang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2047-9. PubMed ID: 19033125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningeal carcinomatosis as the first manifestation of malignant carcinomatosis.
    Gdovinova Z; Feketeova E; Szilasiova J; Havlikova E; Banik P
    Bratisl Lek Listy; 2009; 110(8):490-5. PubMed ID: 19750988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
    Kak M; Nanda R; Ramsdale EE; Lukas RV
    J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of leptomeningeal metastases: Prognostic factors and associated outcomes.
    Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H
    J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purely extramedullary spinal germinomas: are they more aggressive?
    Tekkok I
    Acta Neurochir (Wien); 2009 Aug; 151(8):983-4. PubMed ID: 19337687
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of leptomeningeal carcinomatosis and challenges of trial design.
    Gill CM; Brastianos PK
    Curr Opin Oncol; 2019 Nov; 31(6):508-513. PubMed ID: 31503030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptomeningeal carcinomatosis as primary presentation of metastatic urothelial cancer.
    Lambird J; Beerepoot L
    BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.
    Dudani S; Mazzarello S; Hilton J; Hutton B; Vandermeer L; Fernandes R; Ibrahim MF; Smith S; Majeed H; Al-Baimani K; Caudrelier JM; Shorr R; Clemons M
    Clin Breast Cancer; 2016 Dec; 16(6):456-470. PubMed ID: 27553811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
    Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
    J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features.
    Bruna J; González L; Miró J; Velasco R; Gil M; Tortosa A;
    Cancer; 2009 Jan; 115(2):381-9. PubMed ID: 19109820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.
    Lee DW; Lee KH; Kim JW; Keam B
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of leptomeningeal metastasis in solid tumors.
    Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
    Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptomeningeal metastases of solid cancer.
    Le Rhun E; Galanis E
    Curr Opin Neurol; 2016 Dec; 29(6):797-805. PubMed ID: 27661208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Numb chin syndrome, migraine-like headache and leptomeningeal spread of a B-cell lymphoma.
    Seidel S; Wöber C
    Headache; 2010 Jan; 50(1):150-1. PubMed ID: 19804399
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic Difficulties in Primary Pauci-Melanotic Leptomeningeal Melanomatosis.
    Koziorowska-Gawron E; Kaczorowski M; Bladowska J; Budrewicz S; Koszewicz M; Hałoń A
    Eur Neurol; 2018; 80(1-2):68-70. PubMed ID: 30231251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.